MPP celebrates WHO’s announcement to establish biomanufacturing training hub in Republic of Korea along with five more countries to receive support from the mRNA hub in South Africa
23 February 2022
Geneva – The Medicines Patent Pool (MPP) celebrates an announcement by the World Health Organization (WHO) to establish a global biomanufacturing training hub in the Republic of Korea that will serve low- and middle-income countries to produce biologicals, such as vaccines, insulin, monoclonal antibodies and cancer treatments.
MPP also welcomes the announcement that five more countries will receive support from the global mRNA technology transfer hub to produce mRNA vaccines. The countries are Bangladesh, Indonesia, Pakistan, Serbia and Vietnam. This announcement comes after African manufacturers from Egypt, Kenya, Nigeria, Senegal and Tunisia were selected last week to receive mRNA technology from the Hub, in addition to Biovac in South Africa.
Companies from Argentina and Brazil, the first countries from the region of the Americas to receive mRNA technology from the Hub in South Africa, are already receiving training.
WHO announcement is available here.
